Areas covered: We review available data and propose a new approach to improve adherence to osteoporosis therapy in clinical practice. We present the current evidence and personal experience from a group of Italian osteoporosis experts.Expert opinion: To improve adherence, we propose a multifaceted approach, which includes the Triad Model suggested by the World Health Organization, direct observed therapy and the use of drugs with longer administration intervals, e.g., zoledronic acid. The integration of these strategies may provide the basis for a marked increase in adherence to osteoporosis therapy, and improved clinical outcomes in a real-life scenario.

Baio, G., Barbagallo, M., D’Avola, G., Di Luccio, A., Di Tanna, G., Falaschi, P., et al. (2011). Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis. EXPERT OPINION ON PHARMACOTHERAPY, 12(2), 257-268 [10.1517/14656566.2011.537259].

Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis

BAIO, GIANLUCA;
2011

Abstract

Areas covered: We review available data and propose a new approach to improve adherence to osteoporosis therapy in clinical practice. We present the current evidence and personal experience from a group of Italian osteoporosis experts.Expert opinion: To improve adherence, we propose a multifaceted approach, which includes the Triad Model suggested by the World Health Organization, direct observed therapy and the use of drugs with longer administration intervals, e.g., zoledronic acid. The integration of these strategies may provide the basis for a marked increase in adherence to osteoporosis therapy, and improved clinical outcomes in a real-life scenario.
Articolo in rivista - Articolo scientifico
Adherence, bisphosphonates, bone density, medication possession ratio, osteoporosis, treatment algorithm
English
2011
12
2
257
268
none
Baio, G., Barbagallo, M., D’Avola, G., Di Luccio, A., Di Tanna, G., Falaschi, P., et al. (2011). Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis. EXPERT OPINION ON PHARMACOTHERAPY, 12(2), 257-268 [10.1517/14656566.2011.537259].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/22294
Citazioni
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
Social impact